R. Drijkoningen

Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas

Isabel Amendoeira, Simonetta Bianchi, Werner Boecker et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 1999 · 117 citations

Medicine, Oncology, Pathology +15

Locally advanced/inflammatory breast cancers treated with intensive epirubicin-based neoadjuvant chemotherapy: are there molecular markers in the primary tumour that predict for 5-year clinical outcome?

Hervé Bonnefoi, Sophie Diebold‐Berger, P. Therasse et al. · Annals of Oncology · 2003 · 72 citations

Medicine, Oncology, Pharmacology +17

Prediction of lymph node involvement in breast cancer from primary tumor tissue using gene expression profiling and miRNAs

Ann Smeets, Anneleen Daemen, Isabelle Vanden Bempt et al. · Breast Cancer Research and Treatment · 2010 · 41 citations

Medicine, Bioinformatics, Oncology +17

Body mass index and HER-2 overexpression in breast cancer patients over 50 years of age

Tim Van Mieghem, Karin Leunen, Nathalie Pochet et al. · Breast Cancer Research and Treatment · 2007 · 21 citations

Medicine, Cancer Biology, Oncology +13

[Guidelines for pathology--supplement to European guidelines for quality assurance in mammography screening. Report by the Pathology Working Group of the European Community].

J P Sloane, Isabel Amendoeira, N. Apostolikas et al. · PubMed · 1997 · 20 citations

Medicine, Pathology, Radiology +17